VKTX Aug 2024 29.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:30AM EDT. Market open.
Loading interactive chart…
- Insider Monkey
Viking Therapeutics (VKTX) Shares Rose in Q1
Fred Alger Management, an investment management company, released its “Alger Small Cap Growth Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. US equities rose in Q1 in anticipation of a soft landing. Corporate earnings added another boost to the soft-landing narrative. Class A shares of the fund outperformed the Russell […]
- Zacks
Viking (VKTX) Falls 10% Despite Upbeat NASH Study Results
Viking Therapeutics (VKTX) reports promising 52-week treatment data from a mid-stage study on its experimental NASH drug. However, shares drop as management did not provide any info on future plans.
- Investor's Business Daily
Viking Therapeutics Stock Crumbles Despite Potential 'Best-In-Class' Liver Disease Drug
Viking Therapeutics stock falls despite seemingly positive test results for a drug that treats a serious liver disease.
© 2024 Yahoo. All rights reserved.